Completed OBSERVATIONAL NCT02133456

A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older

A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older

Sponsor: Centers for Disease Control and Prevention, China

Conditions Influenza Vaccination Adverse Event

Updated 5 times since 2017 Last updated: May 7, 2014 Started: Jan 31, 2014 Primary completion: Mar 31, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Influenza and Vaccination Adverse Event and is currently completed. Centers for Disease Control and Prevention, China leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Apr 2018 — Jan 2021 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention, China
Shanghai Institute Of Biological Products

Data source: Centers for Disease Control and Prevention, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.